Home
Conditions
Erythroblastosis, Fetal

Clinical trial condition

Erythroblastosis, Fetal

Explore clinical trials studying Erythroblastosis, Fetal. Study availability and eligibility vary by location and protocol.

12 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Erythroblastosis, Fetal trial results

Recruiting

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

NCT03775954

Conditions: Anemia, Anemia, Neonatal, Arrhythmias, Cardiac, +53 more
Locations: University of Wisconsin - Madison Madison, Wisconsin, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome

NCT05797272

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Edema, Erythroblastosis, Fetal, +15 more
Locations: The Chinese University of Hong Kong Shatin, Hong Kong

View Trial Details

Enrolling by Invitation

Uncovering the Etiologies of Non-immune Hydrops Fetalis

NCT05528796

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Edema, Erythroblastosis, Fetal, +15 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns

NCT07315126

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +16 more
Locations: Maternité Port Royal Paris, France

View Trial Details

Completed

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

NCT03376438

Conditions: Arrhythmias, Cardiac, Atrial Flutter, Cardiac Conduction System Disease, +29 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

University of California, San Francisco San Francisco, California, United States

Children's Hospital Colorado Denver, Colorado, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 41 locations

View Trial Details

Completed

Bilistick Point-of-care System 2.0 Bilirubin Validation

NCT06058910

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +18 more
Locations: Kettering Health Main Campus Kettering, Ohio, United States

View Trial Details

Completed

Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing

NCT04308603

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Edema, Erythroblastosis, Fetal, +15 more
Locations: CHU Besançon Besançon, France

CHU Pellegrin Bordeaux, France

Hôpital Femme Mère Enfant Bron, France

Hôpital d'Estaing Clermont-Ferrand, France

View all 17 locations

View Trial Details

Completed

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

NCT02691156

Conditions: Bilirubin-induced Neurologic Dysfunction, Brain Diseases, Brain Diseases, Metabolic, +22 more
Locations: Lucile-Packard Children's Hospital at Stanford Stanford, California, United States

View Trial Details

Completed

Efficacy and Safety of Stannsoporfin in Neonates

NCT02685137

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +15 more
Locations: Pennsylvania Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries

NCT01754688

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +14 more
Locations: Massey Street Children's Hospital Lagos, Nigeria

View Trial Details

Erythroblastosis, Fetal

Erythroblastosis, Fetal trial results

Related conditions